|
?:abstract
|
-
Coronaviruses (CoVs) comprise a polymorphic group of respiratory viruses causing acute inflammatory diseases in domestic and agricultural animals (chicken, pig, buffalo, cat and dog) Until recently, this infection in humans was mainly observed during the autumn- winter period and characterized by mild course The situation changed dramatically in 2003, when SARS outbreak caused by pathogenic CoV (SARS-CoV) was recorded in China A decade later, a new CoV outbreak occurred in the form of the Middle East respiratory syndrome (MERS-CoV) The emergency in December 2019 of diseases caused by the new coronavirus (SARS-CoV-2) has already gone down in history as an emergency of international importance, which transformed in the first months of 2020 into the pandemic The novel coronavirus is new not only viewed from its molecular biological features perspective but also from the perspective of possible difficulties of diagnosis and treatment, clinical features, high risk of development of critical conditions and complications, high mortality rate SARS-CoV-2 disease led to the severe bronchopulmonary lesions, varying from dry, debilitating cough to acute respiratory distress syndrome (ARDS) In this report we tried to the highlight the experience gained in the study of novel coronavirus nature, epidemiology, pathogenesis, clinical manifestations and treatment, give information from literature sources
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}